Furthermore, silencing FANCI attenuated the activity of oncogenic Ras signaling that acts as a tumor progression marker, thereby strongly inhibiting its downstream MAPK/ERK and PI3K/AKT/NF-κB signaling cascades in LUAD cells; it also suppressed the ability of tumor-cell proliferation and dissemination. Here, NFKB1 is linked to neoplasm.